STAT· @statnews · X·· 3 小时前精选AI 评分62
AI 导读
两家公司宣布其mRNA疫苗联合免疫疗法大幅降低了黑色素瘤复发风险。但数天后，一家德国药企因早期数据显示无效，终止了其结直肠癌疫苗试验。
推荐理由
同月内两款mRNA肿瘤疫苗出现相反结果，读者可借此观察该技术路线的分化与不确定性。
正文
In August, two companies announced their mRNA vaccine, combined with immunotherapy, substantially cut the risk of returning melanoma.
But days later, a German drugmaker ended its colorectal vaccine trial after early data showed it wasn't working: https://trib.al/cd9Amd1
来源：STAT · x.com